Vis enkel innførsel

Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer

dc.contributor.authorForster, Rachel Bedenis
dc.contributor.authorEngeland, Anders
dc.contributor.authorKvåle, Rune
dc.contributor.authorHjellvik, Vidar
dc.contributor.authorBjørge, Tone
dc.date.accessioned2022-07-29T06:22:36Z
dc.date.available2022-07-29T06:22:36Z
dc.date.created2022-06-24T11:51:42Z
dc.date.issued2022
dc.identifier.citationInternational Journal of Cancer. 2022, .
dc.identifier.issn0020-7136
dc.identifier.urihttps://hdl.handle.net/11250/3009079
dc.language.isoeng
dc.titleAssociation between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer
dc.title.alternativeAssociation between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber11
dc.source.journalInternational Journal of Cancer
dc.identifier.doi10.1002/ijc.34058
dc.identifier.cristin2034790
dc.relation.projectKreftforeningen: 08154-2019
dc.relation.projectKreftforeningen: 182360-2016
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail
Filnavn:
Forster_2022_Ass.pdf
Størrelse:
956.1Kb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel